📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes. (2017)

First Author: Yip BH

Attributed to: Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Acute Myelodi Leukaemia (and Solid Tumours). funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci91363

PubMed Identifier: 28436936

Publication URI: http://europepmc.org/abstract/MED/28436936

Type: Journal Article/Review

Volume: 127

Parent Publication: The Journal of clinical investigation

Issue: 6

ISSN: 0021-9738